Sign In
Buy CODX
$1.44
-0.120 (-7.69%)
At Close: Jul 31, 2026
Co-Diagnostics CEO Egan says individuals and organizations will need DIY coronavirus tests partnered with vaccines to return to normalcy
05:07pm, Wednesday, 31'st Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan told Yahoo! Finance that “we believe COVID-19 will be here till the end of time” -- and that means individuals and organizations will need quick an
Co-Diagnostics CEO Eagan says individuals and organizations will need DIY coronavirus tests partnered with vaccines to return to normalcy
03:09pm, Wednesday, 31'st Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) CEO Dwight Egan told Yahoo! Finance that “we believe COVID-19 will be here till the end of time” -- and that means individuals and organizations will need quick an
Co-Diagnostics, Inc. CEO Discusses Company Strategy for the Future with Yahoo! Finance
09:30am, Wednesday, 31'st Mar 2021
SALT LAKE CITY, March 31, 2021 /PRNewswire/ -- The CEO of Co-Diagnostics, Inc. (Nasdaq: CODX), a molecular diagnostics company with a unique, patented platform for the development of diagnostic test
Co-Diagnostics CEO discusses coronavirus testing: We believe robust testing is key to normalizing
10:39pm, Tuesday, 30'th Mar 2021
coronavirustesting Yahoo Finance's Adam Shapiro and Seana Smith spoke with Co-Diagnostics CEO Dwight Egan about the company's outlook and the latest coronavirus testing methods.
Co-Diagnostics: Buy the Dip?
04:42pm, Monday, 29'th Mar 2021
Analysts following this coronavirus stock have darkened their post-pandemic outlook.
Why Co-Diagnostics Stock Is Dropping Today
04:09pm, Monday, 29'th Mar 2021
The company's recent struggles on the stock market continue.
Co-Diagnostics, DocuSign, Dow, Nomura, Sea and More Monday Afternoon Analyst Calls
11:47am, Monday, 29'th Mar 2021
With the trading day about halfway over, the broad markets were pushing lower. The Dow Jones industrial average and S&P 500 were only down slightly to start the week, while the Nasdaq faced the worst
Co-Diagnostics joins fight against coronavirus (COVID-19) with flagship test
04:00pm, Friday, 26'th Mar 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart Coronavirus Disease detection test in US and globally Earned net income of $42.5 million in 2020 What Co-Diag
Co-Diagnostics turns fight against infectious disease with flagship coronavirus (COVID-19) test
03:55pm, Friday, 26'th Mar 2021
Develops products to detect infectious diseases in humans and animals Offers Logix Smart Coronavirus Disease detection test in US and globally Earned net income of $42.5 million in 2020 What Co-Diag
Why Co-Diagnostics Stock Is Tanking Today
10:40am, Friday, 26'th Mar 2021
Investors didn't like what they heard in the company's fourth-quarter update.
What Investors Didn't Like About Co-Diagnostics' Q4 Update
06:00am, Friday, 26'th Mar 2021
The company missed earnings expectations and hinted at slowing growth in 2021.
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2020 Results - Earnings Call Transcript
10:12pm, Thursday, 25'th Mar 2021
Co-Diagnostics, Inc. (CODX) CEO Dwight Egan on Q4 2020 Results - Earnings Call Transcript
CoDiagnostics, Inc. (CODX) Q4 Earnings Lag Estimates
06:11pm, Thursday, 25'th Mar 2021
CoDiagnostics, Inc. (CODX) delivered earnings and revenue surprises of -12.24% and 1.55%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?
Co-Diagnostics posts 2020 net income of $42.5M as its Logix Smart COVID-19 test drove record sales
04:26pm, Thursday, 25'th Mar 2021
Co-Diagnostics Inc (NASDAQ:CODX) announced Thursday that it earned a net income of $42.5 million in 2020 as its Logix Smart coronavirus (COVID-19) test drove record sales. That's a huge turnaround f
Recap: Co-Diagnostics Q4 Earnings
04:19pm, Thursday, 25'th Mar 2021
Shares of Co-Diagnostics (NASDAQ:CODX) moved lower in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share were up 577.78% year over year to $0.43, which m
